Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,766 public trials 5,053 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Investigational Site Number: 0560001 Leuven, Belgium
  • Investigational Site Number: 2500001 Bron, France
  • Investigational Site Number: 2500003 Paris, France
  • Investigational Site Number: 2500002 Paris, France
View all 14 locations
View Trial Details
Recruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT05494346

Conditions
Acute Rhinitis, Airway Obstruction, Allergic Rhinitis, +27 more
Locations
  • Cabinet Médical Blainville-sur-Orne, France
  • Cabinet Médical Caen Caen, France
  • MSP du Haut Anjou Châteauneuf-sur-Sarthe, France
  • Cabinet Médical Gainneville Gainneville, France
View Trial Details
Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 89 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

NCT05776927

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Krugersdorp, Gauteng, South Africa
  • Novartis Investigative Site Lenasia, Gauteng, South Africa
  • Novartis Investigative Site Germiston, Gauteng, South Africa
  • Novartis Investigative Site Tarnów, Poland
View Trial Details
Recruiting

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

NCT07201558

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Fullerton, California, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Allen, Texas, United States
View all 34 locations
View Trial Details

Related conditions